Search for a trial

COBRA treat-to-target trial

The objective of this study is twofold. First, we want to investigate the effectiveness of a COBRA-plus therapy after incomplete response on COBRA-light therapy after 13 weeks to improve the percentage of RA-patients with a high disease activity and…

A Phase 1, non-randomized, fixed sequence, open-label, drug-drug interaction study to evaluate the effect of GLPG3970 on the pharmacokinetics of methotrexate and sulfasalazine in adult, healthy
subjects

Primary:To evaluate the effect of GLPG3970 on the pharmacokinetics (PK) of methotrexate (MTX) and its active metabolite 7-hydroxymethotrexate (7-OH MTX) in healthy subjectsTo evaluate the effect of GLPG3970 on the PK of sulfasalazine and its active…